Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis-Reference-Cited by-同舟云学术

Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis

Published:2015-07-30 Issue:3 Volume:62 Page:715-725
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Saxena Varun¹,Nyberg Lisa²,Pauly Marypat³,Dasgupta Aditi¹,Nyberg Anders²,Piasecki Barbara⁴,Winston Bradley⁵,Redd Jacquelyn⁵,Ready Joanna³,Terrault Norah A.¹

Affiliation:

1. University of California San Francisco; San Francisco CA

2. Kaiser Permanente Southern California; San Diego CA

3. Kaiser Permanente Northern California; Oakland CA

4. Kaiser Permanente Colorado; Denver CO

5. Kaiser Permanente Mid-Atlantic; Rockville MD.

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.27922/fullpdf

Reference18 articles.

1. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study;Lawitz;Lancet,2014

2. Simeprevir [package insert]. Titusville 2013

3. Sofosbuvir [package insert]. Foster City 2013

4. Hepatic decompensation likely attributable to simeprevir in patients with advanced cirrhosis;Stine;Dig Dis Sci,2015

5. Hepatitis C direct antiviral drugs and hepatic decompensation in patients with advanced cirrhosis: culprit or innocent bystander?;Saxena;Dig Dis Sci,2015

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing HBV and HCV Infection Pre- and Post-liver Transplant;Journal of Clinical and Experimental Hepatology;2024-03

2. Regeneration medicine;Advanced Biologic Drugs and Manufacturing Process;2024

3. Direct-Acting Antivirals for HCV Treatment in Decompensated Liver Cirrhosis Patients: A Systematic Review and Meta-Analysis;Journal of Personalized Medicine;2022-09-15

4. Results of interferon-free treatment for HCV-infected patients with decompensated cirrhosis from a Brazilian real-life cohort;Medicine;2022-09-02

5. Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study;The Brazilian Journal of Infectious Diseases;2022-09